Alar Pharmaceuticals Inc. (TPEX:6785)

Alar Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	17,869	9,452	11,942	6,555	2,608	2,793
Market Cap Growth	107.36%	-20.85%	82.17%	151.37%	-6.63%	-
Enterprise Value	15,534	7,028	11,326	6,046	2,053	2,171
Last Close Price	267.50	141.26	208.00	114.18	45.42	48.65
PE Ratio	-	520.21	31.21	-	-	-
PS Ratio	14260.97	1624.93	25.45	8193.75	-	4655.00
PB Ratio	7.38	3.79	13.31	12.74	4.88	4.67
P/TBV Ratio	7.38	3.79	13.31	12.74	4.88	4.67
P/FCF Ratio	-	-	30.06	-	-	-
P/OCF Ratio	-	-	29.59	-	-	-
EV/Sales Ratio	-	1208.22	24.14	7557.22	-	3617.60
EV/EBITDA Ratio	-	-	29.22	-	-	-
EV/EBIT Ratio	-	-	29.38	-	-	-
EV/FCF Ratio	-174.75	-	28.51	-	-	-
Debt / Equity Ratio	0.00	0	0.00	0.01	0.00	0.00
Debt / EBITDA Ratio	-	-	0.00	-	-	-
Debt / FCF Ratio	-	-	0.00	-	-	-
Net Debt / Equity Ratio	-0.96	-0.97	-1.00	-0.94	-0.97	-0.93
Net Debt / EBITDA Ratio	18.19	37.14	-2.31	10.95	5.71	3.32
Net Debt / FCF Ratio	26.27	34.80	-2.25	14.19	7.97	3.93
Asset Turnover	0	0.00	0.63	0.00	-	0.00
Quick Ratio	26.06	44.14	11.98	90.70	116.51	135.92
Current Ratio	26.49	44.33	12.08	92.66	118.67	143.31
Return on Equity (ROE)	-1.20%	1.07%	54.21%	-3.79%	-11.34%	-36.17%
Return on Assets (ROA)	-3.24%	-2.41%	32.22%	-5.47%	-10.20%	-26.68%
Return on Invested Capital (ROIC)	-135.76%	-104.19%	2250.88%	-197.02%	-336.68%	-556.61%
Return on Capital Employed (ROCE)	-5.40%	-2.70%	42.90%	-9.00%	-17.40%	-28.50%
Earnings Yield	-0.16%	0.19%	3.20%	-0.30%	-2.46%	-5.11%
FCF Yield	-0.50%	-0.74%	3.33%	-0.52%	-2.49%	-5.10%
Dividend Yield	0.09%	0.18%	0.72%	-	-	-
Payout Ratio	-	551.46%	-	-	-	-
Buyback Yield / Dilution	-4.69%	-16.08%	-0.09%	-	-14.21%	-42.59%
Total Shareholder Return	-4.59%	-15.90%	0.63%	-	-14.21%	-42.59%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.